Cite
HARVARD Citation
Kiely, P. et al. (2013). FRI0180 Higher likelihood of response in rheumatoid arthritis patients treated in a real-life setting with adalimumab in combination with methotrexate, but not with other dmards, versus adalimumab monotherapy. Annals of the rheumatic diseases. pp. A432-A433. [Online].